Behind the Bell CRISPR Therapeutics
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=JrY5baMCbC0
In this episode of Behind the Bell, CRISPR Therapeutics Chairman CEO Samarth Kulkarni joined us at MarketSite to commemorate the historic first-ever approval of a CRISPR-based therapy and to celebrate innovation as CRISPR Therapeutics continues to expand and advance its pipeline of programs for rare and common diseases. • Watch more of Behind the Bell on Nasdaq.com: https://www.nasdaq.com/news-and-insig...
#############################
